AgomAb Therapeutics NV

US$7.63As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AGMBHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$376.0M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$9.53
24.80%
(86.40%)
Hold 8|5|1|0|8
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.11
0.12
0.12
0.13
14.23%
6.46%
6.60%
14.74%
Revenue€M
18.37
18.31
18.09
18.69
10.34%
6.42%
4.99%
4.86%
Peers (US$376.0M)
Cap (US$)
PE
1.993B
19.36x
374.4M
39.28x
Capital
TTM
5Y
10Y
Leveragex
2.404
0.144
0.094
EBIT/Intx
0.205
0.513
0.395
Own earn%
109.52
89.77
64.90
Sh yield%
47.58
6.36
8.22
Owners
Insiders/Inst%
6.88
21.21
Short interest%
1.71
SBC / revenue%
5.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
11–16
$1 testx
—
Incr. ROIC%
4